The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.5M data for 728K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

19 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Binding cooperativity between a ligand carbonyl group and a hydrophobic side chain can be enhanced by additional H-bonds in a distance dependent manner: A case study with thrombin inhibitors.EBI
The State University of New York
Additivity or cooperativity: which model can predict the influence of simultaneous incorporation of two or more functionalities in a ligand molecule?EBI
The State University of New York
Thiorhodamines containing amide and thioamide functionality as inhibitors of the ATP-binding cassette drug transporter P-glycoprotein (ABCB1).EBI
The State University of New York
Water mediated ligand functional group cooperativity: the contribution of a methyl group to binding affinity is enhanced by a COO(-) group through changes in the structure and thermodynamics of the hydration waters of ligand-thermolysin complexes.EBI
The State University of New York
1-Naphthyl and 4-indolyl arylalkylamines as selective monoamine reuptake inhibitors.EBI
The State University of New York
Enhancement of hydrophobic interactions and hydrogen bond strength by cooperativity: synthesis, modeling, and molecular dynamics simulations of a congeneric series of thrombin inhibitors.EBI
The State University of New York
Rhodamine inhibitors of P-glycoprotein: an amide/thioamide"switch" for ATPase activity.EBI
The State University of New York
Pitfalls and Considerations in Determining the Potency and Mutant Selectivity of Covalent Epidermal Growth Factor Receptor Inhibitors.EBI
The State University of New York
Structural Basis for Inhibition of Mutant EGFR with Lazertinib (YH25448).EBI
The State University of New York
Privileged scaffolds for blocking protein-protein interactions: 1,4-disubstituted naphthalene antagonists of transcription factor complex HOX-PBX/DNA.EBI
The State University of New York
Selenorhodamine photosensitizers for photodynamic therapy of P-glycoprotein-expressing cancer cells.EBI
The State University of New York
Chalcogenopyrylium compounds as modulators of the ATP-binding cassette transporters P-glycoprotein (P-gp/ABCB1) and multidrug resistance protein 1 (MRP1/ABCC1).EBI
The State University of New York
Modulating hydrogen-bond basicity within the context of protein-ligand binding: A case study with thrombin inhibitors that reveals a dominating role for desolvation.EBI
The State University of New York
Aminopyrimidine Derivatives as Cyclin-Dependent Kinase InhibitorsBDB
Accutar Biotechnology
Substituted pyrimidinones as agonists of the APJ receptorBDB
Amgen
PARP1 inhibitors and uses thereofBDB
Xinthera
Farnesoid X receptor agonists and uses thereofBDB
Metacrine
Agent for treating synucleinopathyBDB
Tohoku University
Analysis of the Resistance Mechanism of a Benzoxaborole Inhibitor Reveals Insight into the Leucyl-tRNA Synthetase Editing Mechanism.BDB
Ujf-Embl-Cnrs